Alley Robotics Ventures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
AI & Machine LearningBiotechDeep TechBrooklyn, US
Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in
BoardRohan Ganesh(Director)in
PartnerAbe Murray· solo GP
Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsLux CapitalObvious VenturesAxial VC+3 more
Relay Commerce provides software solutions for e-commerce merchants to help them scale and manage their operations.
E-commerceRetail TechSaaSAtlanta, US
Ricardo Hinds(Executive Officer, Director)
BoardCassie Lancellotti-Young(Director)in
PartnerAbe Murray· solo GP
Co-investorsAlleyCorpPrimary Venture PartnersTwelve Below
Syenex provides cell delivery technologies and contract development services for therapeutic cell engineering, serving biopharmaceutical companies developing cell-based therapies.
BiotechDeep TechMedical DevicesEvanston, US
John D. Rosanelli(Executive Officer, Director)
PartnerAbe Murray· solo GP
Co-investorsAlleyCorpKdT Ventures
XO Health provides risk technology enabling payers and providers to execute value-based contracts in real-time, paired with integrated medical and pharmacy plans designed to reduce costs and improve care outcomes.
HealthtechInsurTechAlpharetta, US
Swati Mathai(Executive Officer, Director)Joseph Mathai(Executive Officer)
BoardAllan Tessler(Director)Jim DeNaut(Director)Averell Mortimer(Director)Todd Meister(Director)
PartnerAbe Murray· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.